Rexulti 1 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F6T8G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,434
Award facts
- Contract value 100% obligated
- $6,433.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order valued at $6,433.92 by the Defense Logistics Agency on December 3, 2025, for the supply of Rexulti 1 mg tablets (30-count packages). The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be executed from the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 4, 2025. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
Rexulti (brexpiprazole) is an atypical antipsychotic medication used to treat schizophrenia and as an adjunctive treatment for major depressive disorder. The award supports the Defense Health Agency's pharmaceutical supply needs for military healthcare systems. AmerisourceBergen's federal contract portfolio demonstrates established capability in delivering brand-name and generic pharmaceuticals, specialty medications, and medical supplies across multiple therapeutic domains to support military and veteran healthcare programs worldwide. The DLA's engagement with AmerisourceBergen reflects the company's position as a critical vendor in the federal medical supply chain, with multiple competitively awarded contracts demonstrating consistent performance in fulfilling federal procurement requirements.
Quick answers
Who was awarded contract SPE2DR26F6T8G?
SPE2DR26F6T8G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26F6T8G worth?
The government has obligated $6,434 on SPE2DR26F6T8G.
Is contract SPE2DR26F6T8G an order under another contract?
Yes. SPE2DR26F6T8G is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6T8G competed?
The extent of competition for SPE2DR26F6T8G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award